Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25

Showing 25 citing articles:

Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 9
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus
Syah Akbarul Adha, Nadiya Nurul Afifah, Irma Rahayu Latarissa, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 135-146
Open Access
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir
Karen Anbro Gammeltoft, Yuyong Zhou, Line A. Ryberg, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1970-1970
Open Access | Times Cited: 11
Oral Bioavailability, Tissue Distribution, Metabolism, and Excretion of Panduratin A from Boesenbergia rotunda Extract in Healthy Rats
Teetat Kongratanapasert, Tussapon Boonyarattanasoonthorn, Kittitach Supannapan, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2905-2917
Open Access | Times Cited: 3
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders
Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China
Pulin Li, Ling Huang, Rui Han, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 469-477
Closed Access | Times Cited: 2
SARS-CoV-2 replication and drug discovery
Farah Nazir, Arnaud John Kombe Kombe, Zunera Khalid, et al.
Molecular and Cellular Probes (2024) Vol. 77, pp. 101973-101973
Open Access | Times Cited: 2
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zhonglei Wang, Xian-qing Song, Wenjing Xu, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3885-3885
Open Access | Times Cited: 7
Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study
Abiden Kapar, Songsong Xie, Zihao Guo, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 569-577
Closed Access | Times Cited: 1
Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines
Qingyuan Yu, Xian Zhou, Rotina Kapini, et al.
Medicines (2024) Vol. 11, Iss. 7, pp. 14-14
Open Access | Times Cited: 1
Telerehabilitation Intervention in Transitional Care for People with COVID-19: Pre-Post Study with a Non-Equivalent Control Group
Neuza Reis, Maria José Costa Dias, Luís Sousa, et al.
Healthcare (2023) Vol. 11, Iss. 18, pp. 2561-2561
Open Access | Times Cited: 3
Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters
Eduardo Gallardo‐Toledo, Megan Neary, Joanne Sharp, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2161-2161
Open Access | Times Cited: 2
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19
Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 487-493
Closed Access
Self-managing symptoms of Long COVID: an education and strategies research protocol
Julia Rybkina, Nithin Jacob, Brenda Colella, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19
Garyphallia Poulakou, Pierre‐Joseph Royer, Nikolay Evgeniev, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Modulation in serum and hematological parameters as a prognostic indicator of COVID-19 infection in hypertension, diabetes mellitus, and different cardiovascular diseases
Muhammad Ishtiaq Jan, Riaz Anwar Khan, Naeem Khan, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access
Polyphenols as Therapeutics in Respiratory Diseases: Moving from Preclinical Evidence to Potential Clinical Applications
Talha Bin Emran, Taslima Akter Eva, Mehrukh Zehravi, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3236-3256
Open Access
Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19
Anabel González‐Acedo, Francisco Javier Manzano‐Moreno, Enrique García‐Recio, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3070-3070
Open Access
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis
Hang Wang, Qiyuan Yang, Yinjun Mao, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-12
Closed Access
Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses
Harry Ridgway, Vasso Apostolopoulos, Graham J. Moore, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1776-1776
Open Access
Prediction, screening, characterization, antioxidant and antihypoxic effects of multi-component zwitterionic cocrystals of dietary flavonoids with picolinic acid
Yao Zou, Decai Gong, Haiguang Yang, et al.
Chinese Chemical Letters (2024), pp. 110768-110768
Closed Access
Evaluation of SARS-CoV-2-Positive Patients with Suspected Reinfection
Aytaj Allahverdiyeva, Ali Ağaçfidan, Lerzan Doğan, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2222-2222
Open Access | Times Cited: 1
The Antidiabetic Mechanisms of Hesperidin: Hesperidin Nanocarriers as Promising Therapeutic Options for Diabetes
Fatemeh Kaviani, Iraj Baratpour, Sorayya Ghasemi
Current Molecular Medicine (2023) Vol. 24, Iss. 12, pp. 1483-1493
Closed Access | Times Cited: 1
Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study
Ahmed Khalil, Asmaa Mohamed, Manasik Hassan, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 949-958
Open Access | Times Cited: 1
Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2
Adam Bess, Frej Berglind, Supratik Mukhopadhyay, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Page 1

Scroll to top